338 related articles for article (PubMed ID: 10599270)
1. [Hypertriglyceridemia: danger for the arteries].
Chanu B
Presse Med; 1999 Nov; 28(36):2011-7. PubMed ID: 10599270
[TBL] [Abstract][Full Text] [Related]
2. The triglyceride connection in atherosclerosis.
Geurian K; Pinson JB; Weart CW
Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
Grundy SM
Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
[TBL] [Abstract][Full Text] [Related]
4. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
Schwandt P
Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
[TBL] [Abstract][Full Text] [Related]
5. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
6. Triglycerides and coronary risk in women and the elderly.
LaRosa JC
Arch Intern Med; 1997 May; 157(9):961-8. PubMed ID: 9140266
[TBL] [Abstract][Full Text] [Related]
7. [Metabolism of atherogenic lipoproteins].
Beucler I; Turpin G
Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574
[TBL] [Abstract][Full Text] [Related]
8. Postprandial hypertriglyceridemia as a coronary risk factor.
Borén J; Matikainen N; Adiels M; Taskinen MR
Clin Chim Acta; 2014 Apr; 431():131-42. PubMed ID: 24508990
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression enhances atherogenicity of lipid profile after transplantation.
Quaschning T; Mainka T; Nauck M; Rump LC; Wanner C; Krämer-Guth A
Kidney Int Suppl; 1999 Jul; 71():S235-7. PubMed ID: 10412786
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology of hypertriglyceridemia].
Imano H; Iso H
Nihon Rinsho; 2013 Sep; 71(9):1528-35. PubMed ID: 24205710
[TBL] [Abstract][Full Text] [Related]
11. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
Grundy SM; Vega GL
Arch Intern Med; 1992 Jan; 152(1):28-34. PubMed ID: 1728925
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of lipoprotein fractions in men with arteriosclerosis obliterans].
Karádi I; Szabolcs Z; Szénási P; Hosszúfalusi N; Császár A; Kusztos R; Romics L
Orv Hetil; 1989 Jul; 130(28):1489-92. PubMed ID: 2748165
[TBL] [Abstract][Full Text] [Related]
13. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
14. Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment.
Ferguson EE
Dis Mon; 2000 Jul; 46(7):421-503. PubMed ID: 10943222
[TBL] [Abstract][Full Text] [Related]
15. Serum triglycerides and risk of cardiovascular disease.
Boullart AC; de Graaf J; Stalenhoef AF
Biochim Biophys Acta; 2012 May; 1821(5):867-75. PubMed ID: 22015388
[TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.
Tenenbaum A; Klempfner R; Fisman EZ
Cardiovasc Diabetol; 2014 Dec; 13():159. PubMed ID: 25471221
[TBL] [Abstract][Full Text] [Related]
17. Triglycerides and atherogenic lipoproteins: rationale for lipid management.
Krauss RM
Am J Med; 1998 Jul; 105(1A):58S-62S. PubMed ID: 9707269
[TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia: a review beyond low-density lipoprotein.
Rapp RJ
Cardiol Rev; 2002; 10(3):163-72. PubMed ID: 12047794
[TBL] [Abstract][Full Text] [Related]
19. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
Alaupovic P; Blankenhorn DH
Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
[TBL] [Abstract][Full Text] [Related]
20. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
Walsh BW; Sacks FM
J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
